ENvue Medical, Inc.
FEEDNasdaqHealthcare · Orthopedic, Prosthetic & Surgical Appliances & Supplies · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $2.6M | $2.6M | $2.3M | $752,000 | $1.7M | $623,000 |
| Operating income | −$22.9M | −$3.6M | −$3.4M | −$5.0M | −$5.7M | −$4.7M |
| Net income | −$18.2M | −$3.7M | −$3.7M | −$5.4M | −$14.3M | −$4.3M |
| Total assets | $41.1M | $3.6M | $6.7M | $5.9M | $8.6M | $8.2M |
| Total liabilities | $7.6M | $3.0M | $2.7M | $2.6M | $2.3M | $5.8M |
| Equity | $33.5M | $627,000 | $4.0M | $3.2M | $6.3M | $2.4M |
| EPS (diluted) | $-26.69 | $-13.73 | $-23.32 | $-3.84 | $-11.35 | — |
| Shares out. | 759,297 | 2.8M | 1.7M | 28.0M | 24.1M | 4.3M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −896.6%
- Net margin
- −712.3%
- Return on equity
- −54.3%
- Return on assets
- −44.2%
- Return on capital (ROCE)
- −66.4%
- Liabilities / assets
- 18.5%
- Debt / equity
- 0.23×
- Book value / share
- $44.12
- Revenue growth (YoY)
- −0.2%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -6.20distress
- Accruals / assets
- −21.4%clean
- Beneish M-Score
- 6.68elevated
- Piotroski F-Score
- 4/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 5 warning● 2 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- Negative operating cash flow
- Beneish M-Score elevated — earnings-manipulation screen flag
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗May 15, 2026
- NT 10-Kmissed a reporting deadline ↗Mar 31, 2026
- NT 10-Qmissed a reporting deadline ↗Aug 14, 2025
- NT 10-Qmissed a reporting deadline ↗May 15, 2025
- NT 10-Kmissed a reporting deadline ↗Apr 1, 2024
- NT 10-Kmissed a reporting deadline ↗Mar 31, 2023
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Glibert Christian MichaelActivist (13D)Apr 17, 2026
- Bank Of America Corp /De/Passive (13G)Mar 6, 2026
- Alpha Capital AnstaltPassive (13G)May 19, 2025
- Armistice Capital, LlcPassive (13G)May 15, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Glibert Christian Michael | Apr 15, 2026 | J | 0 | $0.00 |
| Glibert Christian Michael10% owner | Jan 14, 2026 | Buy | 240,000 | $2.67 |
| Bank Of America Corp /De/10% owner | Feb 2, 2026 | Sell | 100 | $3.05 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 163,391 | 1.0 | +1387.8% |
| Apr 30, 2026 | 10,982 | 1.0 | -32.4% |
| Apr 15, 2026 | 16,233 | 1.0 | -96.5% |
| Mar 31, 2026 | 470,305 | 1.0 | +430.2% |
| Mar 13, 2026 | 88,708 | 1.0 | -49.8% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Director / officer changeFeb 6, 2026
- Entered a material agreement · Modified shareholder rights · Amended charter or bylawsJan 30, 2026
- Director / officer changeDec 30, 2025
- Director / officer changeDec 23, 2025
- Amended charter or bylaws · Regulation FD disclosureDec 12, 2025
- Director / officer change · Shareholder voteDec 5, 2025
- Regulation FD disclosureNov 19, 2025
- Director / officer changeOct 30, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- EFFECTMay 28, 2026
- 424B3May 28, 2026
- S-3May 18, 2026
- 10-QMay 18, 2026
- NT 10-QMay 15, 2026
- 144May 13, 2026
- 4PRIMARY DOCUMENTApr 17, 2026
- SCHEDULE 13D/AApr 17, 2026
- 10-KApr 15, 2026
- NT 10-KMar 31, 2026
- SCHEDULE 13G/AMar 6, 2026
- 3Feb 26, 2026
- 3PRIMARY DOCUMENTFeb 11, 2026
- 4PRIMARY DOCUMENTFeb 11, 2026
- SCHEDULE 13DFeb 11, 2026
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.